ADALIMUMAB
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices
ADALIMUMAB (15160X)
15160X
Manner of administration:Injection
Restriction (Streamlined authority code: 17736)
Indication: Enthesitis/spondylitis related juvenile idiopathic arthritis
Treatment phase: Continuing treatment
